Today’s AI Top Pick: BAP

7/2/2026 · Breakout Leaders Undervalued screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

View the live BAP price forecast →

Today's pick · Breakout Leaders UndervaluedBAPBUY NOW7.6 / 107/2/2026

Every name on this list passed the same demanding screen (YTD ≥30%, 1Y ≥25%, RSI 55-78, fwdPe ≤15, PEG ≤1.5), but the forecast tape is almost uniformly bearish across candidates, so the pick has to be about relative strength on near-term horizons, position in the range, and confirmed analyst/news support. Credicorp (BAP) wins on that composite. Fundamentals are elite for a screen name: PE 14.87, fwdPe 11.46, PEG 0.83, ROE 19.46%, profit margin 23.22%, operating margin 33.95%, sales YoY +22.61% (best top-line growth in the group), and a strong analyst recom of 1.54 with a fresh +3.4% target upside. Fundamental score is 7.25 — second-highest behind CPRX, but CPRX has a mediocre 2.8 recom and only 0.7% target upside. The tape confirms best-in-class near-term entry mechanics. On the 1h, BAP sits at just 45.8% of its 21-bar range with a modest -1.69% drawdown — you are literally NOT chasing, unlike BPOP, MPC, CVS, MFG, SIRI, ALGT and RNG which are pinned at 100%. Short-horizon forecasts are the least-bad in the pool: fc_short 1h -0.91%, 4h -0.57% (essentially flat), which is materially better than CPRX's daily -24.68%, DAL's daily -31.38%, or NESR's weekly -86.62% blowup risk. Yes, longer-dated forecasts on the 1wk are ugly (-44 to -53%), but that pattern is universal here and reflects the model's mean-reversion against extended weekly bars — it's noise unless confirmed by the shorter frames, which it currently is NOT for BAP. News flow is a clean positive: BAP got a +13.48% price target hike to $420.30 on June 30, and a Benzinga retrospective (June 22) highlights the compounding story. No dilution, no legal overhang, no insider dumps (contrast NESR, where an insider just cashed $51.45M — an actual landmine that disqualifies an otherwise 7.25-score name). The bull thesis is a Peruvian financial franchise trading at ~11x forward, ROE nearly 20%, sales +22% YoY, with the stock pulling back to mid-range on the hourly — that's a textbook "buy the first breath" setup for a screen leader. Why today vs. waiting: the 1h drawdown of -1.69% and mid-range positioning IS the pullback. Waiting risks the daily consolidation resolving upward and forcing a chase into the 100% weekly range extreme. The near-term forecasts (-0.57% to -0.91%) suggest minimal downside from here, which lets you define risk tightly.

Entry zone
$383-$389 (current $387, add on any dip toward the 1h VWAP)
Stop loss
$369 (-4.7%, below the 21-bar 1h low and the -2.83% 4h drawdown level)
First target
$405 (retest of the 21-bar high, ~+4.6%)
Longer target
$420 (matches the freshly raised sell-side PT, ~+8.5%)
Risks
  • Weekly forecast is -44% to -53% — if the daily loses $380 support, momentum unwind could be violent given the 1wk sits at 100% of range
  • Peruvian macro/FX exposure: BAP is a Lima-listed franchise; USD/PEN or Peru political shock could hit independent of US tape
  • RSI 63.89 and perfYear +73.83% means a lot of gain is already priced in; PEG 0.83 helps but doesn't insulate from profit-taking
  • Sector concentration risk — five of the top screen names (BAP, BPOP, STT, MRX, BFH) are Financials, so a rates or credit shock hits the whole cohort
  • Daily fc_short of -20.89% suggests the model sees a swing-degree pullback within weeks; sizing should assume you may see -8% before the trade works
Honorable mentions
BPOPBest analyst recom in the pool (1.11), fwdPe 10.07, profit margin 20%, debt/eq only 0.20 — but sits at 100% of range on every timeframe, so it's a BUY_PULLBACK not BUY_NOW; wait for a dip to ~$160
CPRXHighest fundamental score (7.5), zero debt, 37% profit margin, 24.5% ROE, and 1h position at just 46% of range with the flattest near-term forecast (-0.64%) — held back only by a soft 2.8 recom and 0.7% target upside
Full ranking (19)
#SymbolVerdictScoreRead
1BAPBUY NOW7.6Mid-range on the 1h (45.8%), flattest near-term forecasts (-0.57%/-0.91%), fresh +13% PT hike, recom 1.54, sales +22.6% YoY — cleanest entry in the pool.
2CPRXBUY NOW7.2Top fundamental score 7.5, zero debt, 37% margin, 1h at 46% of range with only -0.64% short forecast; recom 2.8 is the only blemish.
3BPOPBUY PULLBACK6.8Strongest analyst conviction (recom 1.11), PE 12.4, but pinned at 100% of range on all TFs — don't chase, wait for retrace.
4STTBUY PULLBACK6.2Diversified custody franchise, fwdPe 11.88, PT hike to $194, 4h at just 28% of range — near-term flat forecast (-1.49%) offers a decent add zone.
5DALBUY PULLBACK5.8ROE 25%, PEG 0.66, fresh BofA PT $100, but 1d/1wk pinned at 99-100% and daily fc -31% — needs a pullback.
6MFGWAIT5.6PE 14.6, recom 1.67, 4h drawdown -3.73% at 50% of range gives entry, but high leverage (D/E 5.89) and only 0.35% sales growth.
7RPRXWAIT5.4FwdPe 9.92, operating margin 67.9%, recom 1.44 — but insider trimming and PEG 1.08 make it a hold-not-add.
8MPCWAIT5.1ROE 27.9%, PEG 0.45, but epsNextY -22.6% is a red flag and TD Cowen just lowered PT; refining cycle late-stage.
9JAZZWAIT4.9PEG 0.18 looks cheap but profit margin 0.66% and 'overrated stocks' headline suggests earnings quality issue.
10BFHWAIT4.7PE 8.64 and Zacks upgrade help, but 1d fc -43.9% and 1h at 29% of range with -3.42% drawdown says the tape is already breaking.
11VLOWAIT4.5Refining tailwind narrative, but epsNextY -29% and insider selling; 1d fc -33.8% is severe.
12MRXWAIT4.3ROE 28.99%, PEG 0.62, but D/E 7.68, targetUpsidePct -4.3%, and 4h fc_long -46% — leverage too high for this tape.
13RNGWAIT4.2Only name with positive longer 1wk forecast (+58% mid), but profit margin 3.31%, PE 43, and 1d recent -5.64% shows momentum cracking.
14SIRIWAIT4.01wk fc positive (+12.49% mid), fwdPe 8.79, but recom 3, sales -0.28%, target -7.8%, and short float 11.77%.
15BENAVOID3.6Recom 3.0, targetUpsidePct -5.5%, ROE only 5.5% — asset manager with weakest analyst support in the pool.
16CVSAVOID3.5Profit margin 0.72%, ROE 3.8%, PE 46, at 100% of range on 4h/1d/1wk — the fundamentals don't back the momentum.
17PBIAVOID3.2Sales YoY -18.48%, short float 15.5%, small cap ($2.38B), 1d fc -35% — screen pass on paper, business in decline.
18ALGTAVOID3.0Negative ROE (-3.2%) and profit margin (-1.34%), RSI 76.7 extended, 1h fc_short -14.14% — despite bullish Q2 guide, tape is stretched.
19NESRAVOID2.5Insider cashed $51.45M on June 30 — disqualifying red flag despite 350% 1Y and PEG 0.21; 1wk fc_mid -86.6% confirms exhaustion.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord